Phase II Study of Pembrolizumab in Combination With Binimetinib and Bevacizumab in Patients With Refractory Colorectal Cancer
Phase of Trial: Phase II
Latest Information Update: 16 Nov 2018
At a glance
- Drugs Bevacizumab (Primary) ; Binimetinib (Primary) ; Pembrolizumab (Primary)
- Indications Adenocarcinoma; Colorectal cancer
- Focus Therapeutic Use
- 02 Nov 2018 Status changed from not yet recruiting to recruiting.
- 05 Sep 2018 Planned initiation date changed from 1 Aug 2018 to 1 Oct 2018.
- 27 Jun 2018 Planned initiation date changed from 1 May 2018 to 1 Aug 2018.